Cargando…
Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies
Biased agonism is a frontier field in GPCR research. Acquired hypocalciuric hypercalcemia (AHH) is a rare disease caused by calcium-sensing receptor (CaSR) autoantibodies, to date, showing either simple blocking or biased properties (i.e., stimulatory or blocking effects on different downstream sign...
Autores principales: | Makita, Noriko, Sato, Junichiro, Manaka, Katsunori, Akahane, Kimiko, Ito, Takahiro, Yamazaki, Hajime, Mizoguchi, Akira, Hikima, Yusuke, Horikoshi, Hirofumi, Nangaku, Masaomi, Iiri, Taroh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714797/ https://www.ncbi.nlm.nih.gov/pubmed/36099030 http://dx.doi.org/10.1172/jci.insight.156742 |
Ejemplares similares
-
Calcimimetic Use in Familial Hypocalciuric Hypercalcemia—A Perspective in Endocrinology
por: Marx, Stephen J.
Publicado: (2017) -
Identification of a novel large CASR deletion in a patient with familial hypocalciuric hypercalcemia
por: García-Castaño, Alejandro, et al.
Publicado: (2018) -
A Novel Missense CASR Gene Sequence Variation Resulting in Familial Hypocalciuric Hypercalcemia
por: Bletsis, Panagiotis, et al.
Publicado: (2022) -
A novel CaSR mutation presenting as a severe case of neonatal familial hypocalciuric hypercalcemia
por: Tonyushkina, Ksenia N, et al.
Publicado: (2012) -
Familial hypocalciuric hypercalcemia caused by homozygous CaSR gene mutation: A case report of a family
por: Wang, Feifei, et al.
Publicado: (2020)